In a large, retrospectively analyzed cohort of patients with advanced EGFR-mutant lung ADC, the concomitant occurrence of a PIK3CA-mutation was a negative prognostic factor associated with decreased median OS, but did not impact benefit from EGFR-TKI monotherapy in terms of objective RR, PFS and duration of response [39]. This evidence concerns the gene PIK3CA and AIDS dementia complex.